Literature DB >> 3588584

Antibodies of the IgE and IgG isotype, serum IgE and circulating immune complexes in schistosomiasis intercalatum.

K Zwingenberger, H Feldmeier, W J Stevens, A Steiner.   

Abstract

Individuals in an advanced phase of infection by Schistosoma intercalatum in whom viable ova are still present in the rectal mucosa but not excreted in detectable quantity, can be distinguished clinically from a younger group of individuals excreting S. intercalatum ova in their faeces. This clear-cut distinction is underlined by findings in parameters of humoral response. The ratio of anticercarial to anti-adult worm antibodies was higher in the group excreting eggs with probably more recent infection. Levels of total serum immunoglobulin were higher in this group, with the exception of serum IgA, which was lower as long as eggs were being excreted. In a later stage of the disease, relatively more IgG seems to be bound in circulating immune complexes. It is postulated that these stage specific patterns of humoral immune response represent the evolution of the host-parasite relationship during the infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3588584     DOI: 10.1007/bf00578515

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  27 in total

1.  [HISTOPATHOLOGIC DIAGNOSIS OF BILHARZIASIS: RESULTS OBTAINED BY ZIEHL-METHYL GREEN STAINING OF RECTAL BIOPSIES].

Authors:  R BECQUET
Journal:  Bull Soc Pathol Exot Filiales       Date:  1964 May-Jul

2.  Class specific antibodies and fluorescent staining patterns in acute and chronic forms of schistosomiasis mansoni.

Authors:  H Y Kanamura; S Hoshino-Shimizu; M E Camargo; L C da Silva
Journal:  Am J Trop Med Hyg       Date:  1979-03       Impact factor: 2.345

Review 3.  Studies on the mechanisms of immunity in human schistosomiasis.

Authors:  A E Butterworth; D W Taylor; M C Veith; M A Vadas; A Dessein; R F Sturrock; E Wells
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

4.  Immunological studies in human schistosomiasis. III. Immunoglobulin levels, antibodies, and delayed hypersensitivity.

Authors:  D Camus; Y Carlier; M Capron; J C Bina; J F Figueiredo; A Prata; A Capron
Journal:  Am J Trop Med Hyg       Date:  1977-05       Impact factor: 2.345

5.  Effect of chemotherapy and reinfection on IgE-containing and IgG-containing circulating immune complexes, serum IgE and IgE antibodies in patients chronically infected with Schistosoma mansoni and Schistosoma haematobium.

Authors:  H Feldmeier; W J Stevens; C H Bridts; A A Daffalla; D W Büttner
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

6.  Kinetics of humoral response during the acute and the convalescent phase of human trichinosis.

Authors:  H Feldmeier; H Fischer; G Blaumeiser
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-04

7.  Kinetics of classes and sub-classes of total immunoglobulins and specific antibodies to Schistosoma mansoni during murine infection.

Authors:  D Bout; R Rousseaux; Y Carlier; A Capron
Journal:  Parasitology       Date:  1980-04       Impact factor: 3.234

8.  IgE responses in human schistosomiasis. I. Quantitation of specific IgE by radioimmunoassay and correlation of results with skin test and basophil histamine release.

Authors:  R Hussain; M Hofstetter; A Goldstone; W B Knight; E A Ottesen
Journal:  Am J Trop Med Hyg       Date:  1983-11       Impact factor: 2.345

9.  [Comparative study of the value of Schistosoma mansoni and Schistosoma haematobium antigens in the indirect immunofluorescent reaction applied to the diagnosis of rectal S. intercalatum bilharziasis].

Authors:  J Lapierre; T Ancelle; C Tourte-Schaefer; A Roose
Journal:  Bull Soc Pathol Exot Filiales       Date:  1978 Nov-Dec

10.  Diagnostic value of rectal biopsy and concentration methods in Schistosomiasis intercalatum: quantitative comparison of three techniques.

Authors:  H Feldmeier; K Zwingenberger; A Steiner; M Dietrich
Journal:  Tropenmed Parasitol       Date:  1981-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.